MediciNova Receives A Notice Of Allowance For A New Patent Covering MN-166 (ibudilast) For The Treatment Of Macular Injury In Japan : Vimarsana.com

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

Card image cap

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , China , Tokyo , Kazuko Matsuda , Geoff Obrien , Exchange Commission , Medicinova Inc , Japan Patent Office , Nasdaq , Nova Receives , New Patent Covering , Macular Injury , Standard Market , Tokyo Stock Exchange , Code Number , Chief Medical Officer , Optical Coherence Tomography , Private Securities Litigation Reform Act ,

vimarsana.com © 2020. All Rights Reserved.